Hospitals in Mexico - Industry Research Report

Sick and tired: The industry is expected to benefit from medical tourism

The COVID-19 pandemic has profoundly impacted Mexico's healthcare system, claiming a substantial number of lives and triggering a drop in hospital revenues throughout 2020. Despite these challenges, COVID-19 catalyzed critical changes in the nation's healthcare landscape. A notable shift is the swift uptake of telemedicine services. The ability to offer remote medical consultations has reduced the risk of in-person appointments and signified a significant transition in hospital operations. Despite a rebound by the end of the period, industry-wide revenue had a slight dip at a CAGR of 0.3% through 2024 and is expected to total MXN 67.9 billion in 2024, when revenue will jump by an estimated 1.3% and profit sits at 18.3% of revenue.

This industry includes licensed general medical and surgical hospitals that provide surgical and nonsurgical diagnostic and medical treatment to inpatients. Hospitals that maintain inpatient beds usually offer other services, including outpatient, operating room and pharmacy services.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.